Differential Expression Analysis
P / FL13 Comparison
Note: The Fold Change value for up-regulated genes is displayed in red; down-regulated values are displayed in blue.
| Gene | Annotation | pval | Fold Change (log2ratio) |
|---|---|---|---|
| cxcl2 | chemokine (C-X-C motif) ligand 2 | 2.150e-6 | 8.696e+0 |
| ccl3 | chemokine (C-C motif) ligand 3 | 2.837e-5 | 7.372e+0 |
| lilrb4 | leukocyte immunoglobulin-like receptor, subfamily B, member 4 | 5.678e-7 | 7.072e+0 |
| cd83 | CD83 antigen | 2.717e-6 | 6.875e+0 |
| bhlhb2 | basic helix-loop-helix domain containing, class B2 | 5.758e-8 | 6.600e+0 |
| pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 | 8.984e-8 | 6.510e+0 |
| lgals3 | lectin, galactose binding, soluble 3 | 1.107e-4 | 6.451e+0 |
| atf3 | activating transcription factor 3 | 7.719e-6 | 6.364e+0 |
| fos | FBJ osteosarcoma oncogene | 2.480e-5 | 6.190e+0 |
| hspa1a | heat shock protein 1A | 4.383e-7 | 6.178e+0 |
| rgs1 | regulator of G-protein signaling 1 | 4.253e-6 | 6.169e+0 |
| cxcl3 | chemokine (C-X-C motif) ligand 3 | 8.936e-4 | 6.075e+0 |
| il1b | interleukin 1 beta | 5.471e-4 | 6.035e+0 |
| s100a9 | S100 calcium binding protein A9 (calgranulin B) | 1.052e-3 | 5.835e+0 |
| slfn4 | schlafen 4 | 1.320e-3 | 5.734e+0 |
| irg1 | immunoresponsive gene 1 | 9.526e-5 | 5.709e+0 |
| spp1 | secreted phosphoprotein 1 | 1.212e-3 | 5.696e+0 |
| cd14 | CD14 antigen | 1.409e-3 | 5.676e+0 |
| olr1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 4.731e-5 | 5.669e+0 |
| ctss | cathepsin S | 4.141e-4 | 5.652e+0 |
| hspa1b | heat shock protein 1B | 4.039e-8 | 5.649e+0 |
| cxcl10 | chemokine (C-X-C motif) ligand 10 | 1.262e-5 | 5.535e+0 |
| cpa3 | carboxypeptidase A3, mast cell | 1.848e-7 | 5.471e+0 |
| perp | PERP, TP53 apoptosis effector | 3.096e-6 | 5.438e+0 |
| fosb | FBJ osteosarcoma oncogene B | 7.166e-6 | 5.422e+0 |
| cd69 | CD69 antigen | 2.568e-5 | 5.412e+0 |
| ptgs2 | prostaglandin-endoperoxide synthase 2 | 7.349e-4 | 5.402e+0 |
| s100a8 | S100 calcium binding protein A8 (calgranulin A) | 1.940e-3 | 5.372e+0 |
| f13a1 | coagulation factor XIII, A1 subunit | 3.147e-5 | 5.329e+0 |
| emilin2 | elastin microfibril interfacer 2 | 1.873e-6 | 5.314e+0 |
| rmcs5 | response to metastatic cancers 5 | 2.797e-4 | 5.219e+0 |
| mpeg1 | macrophage expressed gene 1 | 7.597e-4 | 5.185e+0 |
| chi3l3 | chitinase 3-like 3 | 4.588e-3 | 5.149e+0 |
| cxcl1 | chemokine (C-X-C motif) ligand 1 | 2.650e-3 | 5.089e+0 |
| phlda1 | pleckstrin homology-like domain, family A, member 1 | 6.612e-8 | 5.028e+0 |
| aa467197 | expressed sequence AA467197 | 3.159e-4 | 5.003e+0 |
| stfa1 | stefin A1 | 3.876e-4 | 4.960e+0 |
| egr2 | early growth response 2 | 9.892e-4 | 4.932e+0 |
| nr4a1 | nuclear receptor subfamily 4, group A, member 1 | 7.191e-7 | 4.912e+0 |
| fcgr3 | Fc receptor, IgG, low affinity III | 7.671e-6 | 4.789e+0 |
| gzmb | granzyme B | 1.400e-6 | 4.769e+0 |
| klf4 | Kruppel-like factor 4 (gut) | 2.962e-5 | 4.745e+0 |
| h2-eb1 | histocompatibility 2, class II antigen E beta | 9.004e-4 | 4.735e+0 |
| il6 | interleukin 6 | 3.780e-3 | 4.578e+0 |
| a130040m12rik | RIKEN cDNA A130040M12 gene | 1.488e-6 | 4.552e+0 |
| ai607873 | expressed sequence AI607873 | 7.841e-3 | 4.510e+0 |
| bcl2a1a | B-cell leukemia/lymphoma 2 related protein A1a | 4.295e-4 | 4.477e+0 |
| 9830134c10rik | RIKEN cDNA 9830134C10 gene | 6.348e-6 | 4.465e+0 |
| thbs1 | thrombospondin 1 | 3.546e-3 | 4.463e+0 |
| 2210403k04rik | RIKEN cDNA 2210403K04 gene | 2.017e-6 | 4.442e+0 |
| ccl2 | chemokine (C-C motif) ligand 2 | 1.069e-2 | 4.422e+0 |
| ccl12 | chemokine (C-C motif) ligand 12 | 3.129e-2 | 4.372e+0 |
| adam8 | a disintegrin and metallopeptidase domain 8 | 8.981e-4 | 4.337e+0 |
| il1r2 | interleukin 1 receptor, type II | 5.445e-6 | 4.335e+0 |
| plk2 | polo-like kinase 2 (Drosophila) | 9.332e-6 | 4.324e+0 |
| clec4d | C-type lectin domain family 4, member d | 1.226e-4 | 4.322e+0 |
| ly86 | lymphocyte antigen 86 | 3.057e-3 | 4.260e+0 |
| c1qb | complement component 1, q subcomponent, beta polypeptide | 2.601e-2 | 4.176e+0 |
| nfkbiz | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 2.942e-7 | 4.171e+0 |
| siglec5 | sialic acid binding Ig-like lectin 5 | 1.066e-4 | 4.164e+0 |
| clec4n | C-type lectin domain family 4, member n | 1.795e-2 | 4.078e+0 |
| socs3 | suppressor of cytokine signaling 3 | 8.503e-4 | 4.078e+0 |
| hdc | histidine decarboxylase | 1.944e-6 | 4.076e+0 |
| 2610034m16rik | RIKEN cDNA 2610034M16 gene | 1.959e-5 | 4.065e+0 |
| gpr97 | G protein-coupled receptor 97 | 1.064e-5 | 4.061e+0 |
| ms4a4c | membrane-spanning 4-domains, subfamily A, member 4C | 1.764e-2 | 4.056e+0 |
| h2-aa | histocompatibility 2, class II antigen A, alpha | 1.144e-3 | 4.049e+0 |
| lpxn | leupaxin | 1.052e-3 | 4.046e+0 |
| h2-q7 | histocompatibility 2, Q region locus 7 | 1.985e-3 | 3.924e+0 |
| ly6c1 | lymphocyte antigen 6 complex, locus C1 | 1.223e-2 | 3.904e+0 |
| cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 1.780e-5 | 3.895e+0 |
| eg622976 | predicted gene, EG622976 | 2.584e-2 | 3.889e+0 |
| cybb | cytochrome b-245, beta polypeptide | 3.342e-3 | 3.881e+0 |
| il1rn | interleukin 1 receptor antagonist | 2.720e-2 | 3.866e+0 |
| cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 4.677e-3 | 3.861e+0 |
| lgmn | legumain | 5.895e-3 | 3.860e+0 |
| clec4a3 | C-type lectin domain family 4, member a3 | 3.666e-2 | 3.817e+0 |
| osm | oncostatin M | 4.054e-3 | 3.781e+0 |
| hck | hemopoietic cell kinase | 1.686e-3 | 3.776e+0 |
| gzmd | granzyme D | 1.064e-2 | 3.753e+0 |
| il1rl1 | interleukin 1 receptor-like 1 | 1.272e-6 | 3.750e+0 |
| il10 | interleukin 10 | 1.956e-2 | 3.746e+0 |
| trem1 | triggering receptor expressed on myeloid cells 1 | 4.419e-4 | 3.721e+0 |
| il1a | interleukin 1 alpha | 1.083e-2 | 3.717e+0 |
| ccl7 | chemokine (C-C motif) ligand 7 | 3.709e-2 | 3.698e+0 |
| ifi204 | interferon activated gene 204 | 3.671e-2 | 3.666e+0 |
| c5ar1 | complement component 5a receptor 1 | 6.023e-3 | 3.662e+0 |
| traf1 | Tnf receptor-associated factor 1 | 2.041e-5 | 3.644e+0 |
| cst7 | cystatin F (leukocystatin) | 1.586e-4 | 3.635e+0 |
| clec7a | C-type lectin domain family 7, member a | 1.250e-2 | 3.610e+0 |
| areg | amphiregulin | 9.080e-3 | 3.610e+0 |
| pyhin1 | pyrin and HIN domain family, member 1 | 9.423e-3 | 3.604e+0 |
| slc11a1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 1.192e-2 | 3.603e+0 |
| tnf | tumor necrosis factor | 4.285e-3 | 3.597e+0 |
| ctsg | cathepsin G | 1.151e-4 | 3.592e+0 |
| aif1 | allograft inflammatory factor 1 | 4.065e-2 | 3.592e+0 |
| 0610037m15rik | RIKEN cDNA 0610037M15 gene | 5.589e-3 | 3.582e+0 |
| ankrd57 | ankyrin repeat domain 57 | 2.261e-3 | 3.562e+0 |
| plek | pleckstrin | 3.119e-5 | 3.519e+0 |
| pdpn | podoplanin | 2.181e-2 | 3.517e+0 |
| lpl | lipoprotein lipase | 7.893e-3 | 3.516e+0 |
| il7r | interleukin 7 receptor | 4.674e-3 | 3.500e+0 |
| egr1 | early growth response 1 | 6.361e-5 | 3.470e+0 |
| c3ar1 | complement component 3a receptor 1 | 2.383e-2 | 3.468e+0 |
| dse | dermatan sulfate epimerase | 5.062e-4 | 3.433e+0 |
| ear2 | eosinophil-associated, ribonuclease A family, member 2 | 3.181e-2 | 3.406e+0 |
| prdm1 | PR domain containing 1, with ZNF domain | 1.401e-4 | 3.389e+0 |
| cxcr7 | chemokine (C-X-C motif) receptor 7 | 1.123e-3 | 3.374e+0 |
| btla | B and T lymphocyte associated | 1.533e-4 | 3.365e+0 |
| c1qc | complement component 1, q subcomponent, C chain | 3.106e-2 | 3.364e+0 |
| map3k8 | mitogen-activated protein kinase kinase kinase 8 | 4.272e-4 | 3.354e+0 |
| ccr7 | chemokine (C-C motif) receptor 7 | 1.200e-3 | 3.344e+0 |
| 4930431b09rik | RIKEN cDNA 4930431B09 gene | 1.323e-3 | 3.321e+0 |
| fcgr4 | Fc receptor, IgG, low affinity IV | 1.571e-2 | 3.321e+0 |
| tubb2b | tubulin, beta 2b | 4.260e-7 | 3.321e+0 |
| rnf128 | ring finger protein 128 | 2.761e-3 | 3.320e+0 |
| cebpa | CCAAT/enhancer binding protein (C/EBP), alpha | 7.173e-4 | 3.318e+0 |
| pira6 | paired-Ig-like receptor A6 | 3.990e-4 | 3.308e+0 |
| klrd1 | killer cell lectin-like receptor, subfamily D, member 1 | 3.332e-7 | 3.289e+0 |
| trap1a | tumor rejection antigen P1A | 1.655e-2 | 3.284e+0 |
| itgax | integrin alpha X | 7.154e-3 | 3.258e+0 |
| ier3 | immediate early response 3 | 7.896e-6 | 3.236e+0 |
| 5133401h06rik | RIKEN cDNA 5133401H06 gene | 4.348e-3 | 3.236e+0 |
| pdgfrb | platelet derived growth factor receptor, beta polypeptide | 2.916e-7 | 3.231e+0 |
| csf1r | colony stimulating factor 1 receptor | 1.185e-4 | 3.227e+0 |
| mylk3 | myosin light chain kinase 3 | 4.569e-5 | 3.206e+0 |
| ai426953 | expressed sequence AI426953 | 7.493e-5 | 3.193e+0 |
| tnfaip3 | tumor necrosis factor, alpha-induced protein 3 | 2.333e-4 | 3.184e+0 |
| pira1 | paired-Ig-like receptor A1 | 3.687e-5 | 3.171e+0 |
| gadd45b | growth arrest and DNA-damage-inducible 45 beta | 9.583e-5 | 3.171e+0 |
| ccl6 | chemokine (C-C motif) ligand 6 | 2.030e-2 | 3.158e+0 |
| slc15a3 | solute carrier family 15, member 3 | 8.942e-3 | 3.158e+0 |
| klf2 | Kruppel-like factor 2 (lung) | 1.502e-4 | 3.149e+0 |
| arg2 | arginase type II | 3.380e-2 | 3.117e+0 |
| gpc4 | glypican 4 | 1.057e-4 | 3.110e+0 |
| car1 | carbonic anhydrase 1 | 1.411e-4 | 3.109e+0 |
| ccrl2 | chemokine (C-C motif) receptor-like 2 | 1.172e-2 | 3.077e+0 |
| fpr2 | formyl peptide receptor 2 | 2.162e-2 | 3.067e+0 |
| rab20 | RAB20, member RAS oncogene family | 2.308e-2 | 3.061e+0 |
| cdh17 | cadherin 17 | 5.582e-5 | 3.036e+0 |
| nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 5.438e-6 | 3.024e+0 |
| fcgr2b | Fc receptor, IgG, low affinity IIb | 2.993e-3 | 3.017e+0 |
| hmox1 | heme oxygenase (decycling) 1 | 1.944e-2 | 3.015e+0 |
| krt8 | keratin 8 | 2.095e-2 | 2.994e+0 |
| bcl6 | B-cell leukemia/lymphoma 6 | 1.083e-5 | 2.991e+0 |
| 1100001h23rik | RIKEN cDNA 1100001H23 gene | 7.804e-3 | 2.979e+0 |
| cd36 | CD36 antigen | 2.424e-2 | 2.976e+0 |
| maff | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) | 1.727e-4 | 2.957e+0 |
| ear3 | eosinophil-associated, ribonuclease A family, member 3 | 3.829e-2 | 2.956e+0 |
| hbb-y | hemoglobin Y, beta-like embryonic chain | 4.575e-2 | 2.951e+0 |
| dtx4 | deltex 4 homolog (Drosophila) | 2.650e-4 | 2.948e+0 |
| tnfsf13 | tumor necrosis factor (ligand) superfamily, member 13 | 4.140e-2 | 2.945e+0 |
| zfp36 | zinc finger protein 36 | 2.338e-4 | 2.928e+0 |
| c3 | complement component 3 | 1.426e-2 | 2.912e+0 |
| 4631422o05rik | RIKEN cDNA 4631422O05 gene | 7.860e-5 | 2.907e+0 |
| rel | reticuloendotheliosis oncogene | 1.751e-4 | 2.897e+0 |
| ab124611 | cDNA sequence AB124611 | 8.918e-3 | 2.888e+0 |
| golm1 | golgi membrane protein 1 | 3.891e-6 | 2.876e+0 |
| nr4a2 | nuclear receptor subfamily 4, group A, member 2 | 5.898e-8 | 2.874e+0 |
| dusp1 | dual specificity phosphatase 1 | 4.939e-4 | 2.868e+0 |
| bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 1.244e-5 | 2.858e+0 |
| ramp3 | receptor (calcitonin) activity modifying protein 3 | 6.086e-5 | 2.858e+0 |
| emr1 | EGF-like module containing, mucin-like, hormone receptor-like sequence 1 | 2.352e-2 | 2.855e+0 |
| ccl4 | chemokine (C-C motif) ligand 4 | 1.045e-2 | 2.852e+0 |
| 2310043n10rik | RIKEN cDNA 2310043N10 gene | 4.548e-3 | 2.830e+0 |
| kcne3 | potassium voltage-gated channel, Isk-related subfamily, gene 3 | 3.845e-3 | 2.806e+0 |
| havcr2 | hepatitis A virus cellular receptor 2 | 1.044e-2 | 2.780e+0 |
| alox5 | arachidonate 5-lipoxygenase | 6.061e-6 | 2.779e+0 |
| cpeb2 | cytoplasmic polyadenylation element binding protein 2 | 2.873e-4 | 2.777e+0 |
| pdk4 | pyruvate dehydrogenase kinase, isoenzyme 4 | 1.983e-7 | 2.773e+0 |
| ccrn4l | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | 6.906e-5 | 2.763e+0 |
| skil | SKI-like | 1.913e-6 | 2.760e+0 |
| plau | plasminogen activator, urokinase | 1.958e-2 | 2.757e+0 |
| gzmc | granzyme C | 4.238e-3 | 2.733e+0 |
| itgb5 | integrin beta 5 | 5.876e-3 | 2.733e+0 |
| steap4 | STEAP family member 4 | 5.285e-5 | 2.729e+0 |
| atp8b4 | ATPase, class I, type 8B, member 4 | 1.240e-3 | 2.726e+0 |
| gpr183 | G protein-coupled receptor 183 | 1.074e-4 | 2.721e+0 |
| rgs16 | regulator of G-protein signaling 16 | 2.414e-5 | 2.721e+0 |
| gpr84 | G protein-coupled receptor 84 | 5.422e-5 | 2.713e+0 |
| slc24a3 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 | 2.052e-5 | 2.693e+0 |
| slamf7 | SLAM family member 7 | 3.068e-2 | 2.683e+0 |
| 1190002h23rik | RIKEN cDNA 1190002H23 gene | 3.625e-4 | 2.679e+0 |
| cd300lb | CD300 antigen like family member B | 6.677e-3 | 2.674e+0 |
| apoc2 | apolipoprotein C-II | 2.587e-2 | 2.668e+0 |
| ccr1 | chemokine (C-C motif) receptor 1 | 3.779e-2 | 2.666e+0 |
| serpinb1a | serine (or cysteine) peptidase inhibitor, clade B, member 1a | 5.430e-4 | 2.650e+0 |
| tlr13 | toll-like receptor 13 | 1.979e-2 | 2.630e+0 |
| 5033413d16rik | RIKEN cDNA 5033413D16 gene | 7.869e-4 | 2.628e+0 |
| cd180 | CD180 antigen | 1.028e-3 | 2.610e+0 |
| af251705 | cDNA sequence AF251705 | 1.272e-2 | 2.602e+0 |
| 1200016e24rik | RIKEN cDNA 1200016E24 gene | 3.378e-4 | 2.596e+0 |
| nfil3 | nuclear factor, interleukin 3, regulated | 4.771e-4 | 2.596e+0 |
| egr3 | early growth response 3 | 3.595e-8 | 2.588e+0 |
| ai845619 | expressed sequence AI845619 | 7.270e-4 | 2.578e+0 |
| relb | avian reticuloendotheliosis viral (v-rel) oncogene related B | 6.033e-5 | 2.574e+0 |
| mefv | Mediterranean fever | 2.885e-2 | 2.572e+0 |
| dab2 | disabled homolog 2 (Drosophila) | 1.186e-2 | 2.571e+0 |
| errfi1 | ERBB receptor feedback inhibitor 1 | 6.761e-3 | 2.557e+0 |
| nlrp3 | NLR family, pyrin domain containing 3 | 7.772e-3 | 2.550e+0 |
| hp | haptoglobin | 6.723e-3 | 2.548e+0 |
| rabgef1 | RAB guanine nucleotide exchange factor (GEF) 1 | 1.105e-5 | 2.539e+0 |
| ms4a2 | membrane-spanning 4-domains, subfamily A, member 2 | 4.234e-3 | 2.526e+0 |
| dusp5 | dual specificity phosphatase 5 | 1.527e-6 | 2.525e+0 |
| lpcat2 | lysophosphatidylcholine acyltransferase 2 | 2.159e-4 | 2.517e+0 |
| scin | scinderin | 4.301e-8 | 2.515e+0 |
| lin28 | lin-28 homolog (C. elegans) | 2.373e-5 | 2.507e+0 |
| sdc4 | syndecan 4 | 2.472e-2 | 2.505e+0 |
| nfkbid | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta | 1.846e-4 | 2.502e+0 |
| nap1l5 | nucleosome assembly protein 1-like 5 | 2.535e-4 | 2.501e+0 |
| cxcl16 | chemokine (C-X-C motif) ligand 16 | 3.083e-2 | 2.500e+0 |
| tlr7 | toll-like receptor 7 | 6.794e-3 | 2.499e+0 |
| bc035044 | cDNA sequence BC035044 | 1.978e-4 | 2.498e+0 |
| gna14 | guanine nucleotide binding protein, alpha 14 | 5.193e-6 | 2.493e+0 |
| 4732429d16rik | RIKEN cDNA 4732429D16 gene | 1.838e-2 | 2.491e+0 |
| ccl5 | chemokine (C-C motif) ligand 5 | 4.862e-2 | 2.487e+0 |
| speer1-ps1 | spermatogenesis associated glutamate (E)-rich protein 1, pseudogene 1 | 6.383e-3 | 2.478e+0 |
| nkg7 | natural killer cell group 7 sequence | 2.564e-4 | 2.476e+0 |
| pparg | peroxisome proliferator activated receptor gamma | 3.166e-2 | 2.474e+0 |
| dusp8 | dual specificity phosphatase 8 | 5.946e-6 | 2.463e+0 |
| slpi | secretory leukocyte peptidase inhibitor | 3.514e-2 | 2.455e+0 |
| ifitm6 | interferon induced transmembrane protein 6 | 2.965e-2 | 2.438e+0 |
| jun | Jun oncogene | 7.918e-5 | 2.435e+0 |
| sgk1 | serum/glucocorticoid regulated kinase 1 | 1.047e-2 | 2.414e+0 |
| ptgds2 | prostaglandin D2 synthase 2, hematopoietic | 5.536e-3 | 2.407e+0 |
| zbtb16 | zinc finger and BTB domain containing 16 | 1.469e-5 | 2.401e+0 |
| agpat9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | 2.849e-2 | 2.401e+0 |
| gpr174 | G protein-coupled receptor 174 | 1.155e-4 | 2.393e+0 |
| cd244 | CD244 natural killer cell receptor 2B4 | 1.079e-4 | 2.378e+0 |
| c030046g05 | hypothetical protein C030046G05 | 6.935e-6 | 2.377e+0 |
| pmp22 | peripheral myelin protein 22 | 3.802e-2 | 2.374e+0 |
| rnf19b | ring finger protein 19B | 8.856e-4 | 2.368e+0 |
| plaur | plasminogen activator, urokinase receptor | 3.710e-4 | 2.367e+0 |
| klf11 | Kruppel-like factor 11 | 2.952e-5 | 2.358e+0 |
| stx11 | syntaxin 11 | 4.040e-4 | 2.354e+0 |
| akap12 | A kinase (PRKA) anchor protein (gravin) 12 | 1.052e-2 | 2.345e+0 |
| bag3 | BCL2-associated athanogene 3 | 9.523e-4 | 2.334e+0 |
| bmp2 | bone morphogenetic protein 2 | 8.303e-5 | 2.327e+0 |
| g0s2 | G0/G1 switch gene 2 | 1.355e-2 | 2.324e+0 |
| pstpip2 | proline-serine-threonine phosphatase-interacting protein 2 | 1.374e-3 | 2.320e+0 |
| cass4 | Cas scaffolding protein family member 4 | 3.090e-4 | 2.314e+0 |
| flrt3 | fibronectin leucine rich transmembrane protein 3 | 1.176e-2 | 2.309e+0 |
| tuba8 | tubulin, alpha 8 | 1.180e-5 | 2.307e+0 |
| homer2 | homer homolog 2 (Drosophila) | 4.057e-4 | 2.301e+0 |
| pilra | paired immunoglobin-like type 2 receptor alpha | 4.433e-2 | 2.293e+0 |
| csf2rb2 | colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) | 3.262e-3 | 2.293e+0 |
| anxa3 | annexin A3 | 4.427e-4 | 2.292e+0 |
| optn | optineurin | 1.515e-4 | 2.290e+0 |
| lrrc16a | leucine rich repeat containing 16A | 4.617e-3 | 2.289e+0 |
| papss2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 | 1.779e-4 | 2.286e+0 |
| ezr | ezrin | 3.847e-5 | 2.279e+0 |
| btg1 | B-cell translocation gene 1, anti-proliferative | 7.944e-5 | 2.277e+0 |
| nuak2 | NUAK family, SNF1-like kinase, 2 | 9.767e-4 | 2.269e+0 |
| trps1 | trichorhinophalangeal syndrome I (human) | 5.210e-5 | 2.265e+0 |
| hapln1 | hyaluronan and proteoglycan link protein 1 | 3.206e-4 | 2.265e+0 |
| mreg | melanoregulin | 1.348e-3 | 2.259e+0 |
| glis3 | GLIS family zinc finger 3 | 2.944e-3 | 2.250e+0 |
| kel | Kell blood group | 4.890e-6 | 2.248e+0 |
| fyb | FYN binding protein | 2.977e-3 | 2.242e+0 |
| mpo | myeloperoxidase | 9.538e-6 | 2.242e+0 |
| bzrap1 | benzodiazapine receptor associated protein 1 | 7.881e-3 | 2.238e+0 |
| klf6 | Kruppel-like factor 6 | 2.540e-4 | 2.218e+0 |
| cd52 | CD52 antigen | 3.595e-3 | 2.216e+0 |
| lmna | lamin A | 1.325e-7 | 2.210e+0 |
| nucb2 | nucleobindin 2 | 1.898e-3 | 2.205e+0 |
| fgl2 | fibrinogen-like protein 2 | 6.135e-3 | 2.203e+0 |
| slc45a3 | solute carrier family 45, member 3 | 1.854e-5 | 2.195e+0 |
| tubb3 | tubulin, beta 3 | 1.288e-3 | 2.188e+0 |
| myd116 | myeloid differentiation primary response gene 116 | 1.692e-3 | 2.187e+0 |
| lrp1 | low density lipoprotein receptor-related protein 1 | 8.789e-3 | 2.186e+0 |
| ptger2 | prostaglandin E receptor 2 (subtype EP2) | 1.233e-2 | 2.183e+0 |
| ccr2 | chemokine (C-C motif) receptor 2 | 2.101e-2 | 2.180e+0 |
| fhod3 | formin homology 2 domain containing 3 | 2.803e-3 | 2.175e+0 |
| irak2 | interleukin-1 receptor-associated kinase 2 | 1.007e-3 | 2.172e+0 |
| metrnl | meteorin, glial cell differentiation regulator-like | 3.549e-3 | 2.150e+0 |
| cd33 | CD33 antigen | 4.971e-3 | 2.148e+0 |
| ms4a7 | membrane-spanning 4-domains, subfamily A, member 7 | 2.851e-2 | 2.135e+0 |
| rrad | Ras-related associated with diabetes | 2.789e-5 | 2.133e+0 |
| art2a | ADP-ribosyltransferase 2a | 1.072e-2 | 2.120e+0 |
| ccl17 | chemokine (C-C motif) ligand 17 | 7.970e-3 | 2.116e+0 |
| junb | Jun-B oncogene | 5.691e-4 | 2.114e+0 |
| ifi205 | interferon activated gene 205 | 9.507e-3 | 2.111e+0 |
| 1700006j14rik | RIKEN cDNA 1700006J14 gene | 1.034e-3 | 2.109e+0 |
| pmepa1 | prostate transmembrane protein, androgen induced 1 | 2.011e-4 | 2.107e+0 |
| apobec2 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 | 7.229e-4 | 2.103e+0 |
| bcl3 | B-cell leukemia/lymphoma 3 | 2.368e-5 | 2.102e+0 |
| slc16a6 | solute carrier family 16 (monocarboxylic acid transporters), member 6 | 9.300e-5 | 2.093e+0 |
| ptger4 | prostaglandin E receptor 4 (subtype EP4) | 1.183e-2 | 2.091e+0 |
| adamts1 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 | 1.105e-2 | 2.089e+0 |
| stab1 | stabilin 1 | 1.655e-2 | 2.085e+0 |
| adam9 | a disintegrin and metallopeptidase domain 9 (meltrin gamma) | 1.107e-3 | 2.085e+0 |
| cd72 | CD72 antigen | 3.934e-2 | 2.084e+0 |
| rhob | ras homolog gene family, member B | 6.930e-4 | 2.082e+0 |
| btg2 | B-cell translocation gene 2, anti-proliferative | 1.005e-3 | 2.070e+0 |
| lilrb3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 3.533e-3 | 2.070e+0 |
| glipr1 | GLI pathogenesis-related 1 (glioma) | 6.392e-5 | 2.061e+0 |
| slc7a8 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 | 1.331e-3 | 2.058e+0 |
| x99384 | cDNA sequence X99384 | 2.120e-3 | 2.050e+0 |
| trem3 | triggering receptor expressed on myeloid cells 3 | 9.415e-3 | 2.039e+0 |
| loc215866 | hypothetical protein LOC215866 | 1.006e-4 | 2.031e+0 |
| hspb1 | heat shock protein 1 | 8.040e-3 | 2.027e+0 |
| tnfrsf12a | tumor necrosis factor receptor superfamily, member 12a | 8.803e-4 | 2.026e+0 |
| blnk | B-cell linker | 4.250e-2 | 2.023e+0 |
| b4galnt1 | beta-1,4-N-acetyl-galactosaminyl transferase 1 | 2.046e-4 | 2.020e+0 |
| cd97 | CD97 antigen | 1.431e-4 | 2.019e+0 |
| s100a6 | S100 calcium binding protein A6 (calcyclin) | 1.646e-2 | 2.017e+0 |
| sema4a | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A | 2.320e-2 | 2.007e+0 |
| oaf | OAF homolog (Drosophila) | 3.291e-4 | 2.007e+0 |
| bc064078 | cDNA sequence BC064078 | 7.738e-5 | -2.004e+0 |
| gng11 | guanine nucleotide binding protein (G protein), gamma 11 | 1.655e-5 | -2.006e+0 |
| c130015c19 | hypothetical LOC403342 | 5.362e-3 | -2.014e+0 |
| ttc30a1 | tetratricopeptide repeat domain 30A1 | 6.465e-4 | -2.016e+0 |
| lancl3 | LanC lantibiotic synthetase component C-like 3 (bacterial) | 1.815e-3 | -2.017e+0 |
| gm347 | gene model 347, (NCBI) | 1.415e-4 | -2.038e+0 |
| c230011h18rik | RIKEN cDNA C230011H18 gene | 2.569e-5 | -2.040e+0 |
| d9wsu90e | DNA segment, Chr 9, Wayne State University 90, expressed | 9.024e-3 | -2.043e+0 |
| zfp58 | zinc finger protein 58 | 3.356e-3 | -2.051e+0 |
| 8430419k02rik | RIKEN cDNA 8430419K02 gene | 2.641e-5 | -2.058e+0 |
| 545228 | predicted gene, 545228 | 4.090e-4 | -2.062e+0 |
| serpinf1 | serine (or cysteine) peptidase inhibitor, clade F, member 1 | 1.690e-4 | -2.062e+0 |
| bbs10 | Bardet-Biedl syndrome 10 (human) | 8.995e-5 | -2.063e+0 |
| flywch2 | FLYWCH family member 2 | 5.840e-5 | -2.064e+0 |
| tnfrsf18 | tumor necrosis factor receptor superfamily, member 18 | 4.154e-5 | -2.067e+0 |
| 6720457d02rik | RIKEN cDNA 6720457D02 gene | 7.958e-6 | -2.079e+0 |
| s100a16 | S100 calcium binding protein A16 | 2.441e-3 | -2.081e+0 |
| robo4 | roundabout homolog 4 (Drosophila) | 2.525e-3 | -2.082e+0 |
| vnn1 | vanin 1 | 1.176e-2 | -2.091e+0 |
| 9930012k11rik | RIKEN cDNA 9930012K11 gene | 4.209e-5 | -2.097e+0 |
| ttc30b | tetratricopeptide repeat domain 30B | 2.334e-3 | -2.105e+0 |
| 9030619p08rik | RIKEN cDNA 9030619P08 gene | 7.645e-4 | -2.110e+0 |
| 9530010c24rik | RIKEN cDNA 9530010C24 gene | 2.514e-5 | -2.110e+0 |
| armcx1 | armadillo repeat containing, X-linked 1 | 8.184e-4 | -2.114e+0 |
| 2610019n06rik | RIKEN cDNA 2610019N06 gene | 1.150e-4 | -2.117e+0 |
| txnip | thioredoxin interacting protein | 3.467e-6 | -2.131e+0 |
| cpxm1 | carboxypeptidase X 1 (M14 family) | 4.663e-4 | -2.133e+0 |
| 2400009b08rik | RIKEN cDNA 2400009B08 gene | 3.411e-4 | -2.149e+0 |
| gucy1a3 | guanylate cyclase 1, soluble, alpha 3 | 1.121e-4 | -2.150e+0 |
| zfp467 | zinc finger protein 467 | 6.264e-5 | -2.151e+0 |
| thsd1 | thrombospondin, type I, domain 1 | 3.576e-5 | -2.158e+0 |
| cyp7b1 | cytochrome P450, family 7, subfamily b, polypeptide 1 | 3.238e-6 | -2.170e+0 |
| mycn | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 4.178e-6 | -2.174e+0 |
| cadps2 | Ca2+-dependent activator protein for secretion 2 | 3.454e-4 | -2.174e+0 |
| zfp94 | zinc finger protein 94 | 1.480e-4 | -2.176e+0 |
| slamf1 | signaling lymphocytic activation molecule family member 1 | 2.198e-5 | -2.177e+0 |
| zfp708 | zinc finger protein 708 | 1.152e-4 | -2.181e+0 |
| 2610008e11rik | RIKEN cDNA 2610008E11 gene | 6.424e-5 | -2.203e+0 |
| d930050a07rik | RIKEN cDNA D930050A07 gene | 2.248e-4 | -2.206e+0 |
| cyp39a1 | cytochrome P450, family 39, subfamily a, polypeptide 1 | 7.037e-5 | -2.212e+0 |
| cyp4b1 | cytochrome P450, family 4, subfamily b, polypeptide 1 | 3.093e-5 | -2.216e+0 |
| 2810040c05rik | RIKEN cDNA 2810040C05 gene | 1.843e-4 | -2.222e+0 |
| tgtp | T-cell specific GTPase | 1.607e-2 | -2.222e+0 |
| meis1 | Meis homeobox 1 | 7.203e-5 | -2.228e+0 |
| tcfec | transcription factor EC | 1.711e-2 | -2.240e+0 |
| mageh1 | melanoma antigen, family H, 1 | 5.978e-3 | -2.242e+0 |
| hspa12b | heat shock protein 12B | 1.049e-5 | -2.253e+0 |
| gimap8 | GTPase, IMAP family member 8 | 3.659e-4 | -2.257e+0 |
| 4932413o14rik | RIKEN cDNA 4932413O14 gene | 3.510e-3 | -2.261e+0 |
| mamdc2 | MAM domain containing 2 | 1.443e-3 | -2.280e+0 |
| bc043476 | cDNA sequence BC043476 | 1.951e-3 | -2.287e+0 |
| 2900006b11rik | RIKEN cDNA 2900006B11 gene | 5.613e-5 | -2.304e+0 |
| mgam | maltase-glucoamylase | 1.215e-3 | -2.316e+0 |
| 1190002f15rik | RIKEN cDNA 1190002F15 gene | 2.240e-5 | -2.340e+0 |
| a030009h04rik | RIKEN cDNA A030009H04 gene | 2.283e-6 | -2.356e+0 |
| myct1 | myc target 1 | 2.486e-4 | -2.361e+0 |
| 1700012d01rik | RIKEN cDNA 1700012D01 gene | 3.261e-4 | -2.388e+0 |
| gfi1 | growth factor independent 1 | 4.030e-4 | -2.465e+0 |
| hnmt | histamine N-methyltransferase | 3.531e-3 | -2.468e+0 |
| cyp2j9 | cytochrome P450, family 2, subfamily j, polypeptide 9 | 6.153e-6 | -2.481e+0 |
| zfp563 | zinc finger protein 563 | 2.177e-4 | -2.485e+0 |
| eraf | erythroid associated factor | 1.260e-2 | -2.489e+0 |
| a830059i20rik | RIKEN cDNA A830059I20 gene | 2.048e-5 | -2.498e+0 |
| hoxb5 | homeo box B5 | 7.856e-4 | -2.504e+0 |
| mllt3 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 | 3.231e-5 | -2.534e+0 |
| 4833414e09rik | RIKEN cDNA 4833414E09 gene | 2.115e-5 | -2.596e+0 |
| 2810055g20rik | RIKEN cDNA 2810055G20 gene | 1.323e-6 | -2.623e+0 |
| wfdc2 | WAP four-disulfide core domain 2 | 1.758e-4 | -2.645e+0 |
| 6030498e09rik | RIKEN cDNA 6030498E09 gene | 1.375e-4 | -2.646e+0 |
| hbb-b2 | hemoglobin, beta adult minor chain | 4.756e-3 | -2.647e+0 |
| nat1 | N-acetyltransferase 1 (arylamine N-acetyltransferase) | 2.696e-4 | -2.669e+0 |
| 4832441b07rik | RIKEN cDNA 4832441B07 gene | 4.430e-5 | -2.682e+0 |
| 6330403k07rik | RIKEN cDNA 6330403K07 gene | 1.274e-5 | -2.684e+0 |
| pabpc4l | poly(A) binding protein, cytoplasmic 4-like | 3.656e-7 | -2.696e+0 |
| iigp2 | interferon inducible GTPase 2 | 1.356e-3 | -2.702e+0 |
| rbp1 | retinol binding protein 1, cellular | 1.393e-4 | -2.737e+0 |
| ai449310 | expressed sequence AI449310 | 1.078e-3 | -2.745e+0 |
| 1810073o08rik | RIKEN cDNA 1810073O08 gene | 1.687e-4 | -2.767e+0 |
| 1700040l02rik | RIKEN cDNA 1700040L02 gene | 7.813e-5 | -2.805e+0 |
| bc015286 | cDNA sequence BC015286 | 2.214e-4 | -2.814e+0 |
| 1110017f19rik | RIKEN cDNA 1110017F19 gene | 2.732e-5 | -2.824e+0 |
| sox18 | SRY-box containing gene 18 | 2.288e-3 | -2.846e+0 |
| crispld1 | cysteine-rich secretory protein LCCL domain containing 1 | 4.348e-7 | -2.866e+0 |
| trpc6 | transient receptor potential cation channel, subfamily C, member 6 | 1.261e-4 | -2.868e+0 |
| hlf | hepatic leukemia factor | 1.657e-5 | -2.923e+0 |
| eya2 | eyes absent 2 homolog (Drosophila) | 1.756e-5 | -2.924e+0 |
| ddx4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 3.505e-4 | -2.977e+0 |
| slc16a9 | solute carrier family 16 (monocarboxylic acid transporters), member 9 | 7.019e-6 | -2.991e+0 |
| zfp760 | zinc finger protein 760 | 1.799e-6 | -3.137e+0 |
| pdzk1ip1 | PDZK1 interacting protein 1 | 2.032e-7 | -3.145e+0 |
| gprc5b | G protein-coupled receptor, family C, group 5, member B | 4.507e-9 | -3.367e+0 |
| 0610040b09rik | RIKEN cDNA 0610040B09 gene | 6.483e-6 | -3.569e+0 |
| 2010004m13rik | RIKEN cDNA 2010004M13 gene | 1.457e-7 | -3.584e+0 |
| dkk1 | dickkopf homolog 1 (Xenopus laevis) | 5.050e-10 | -4.159e+0 |